Sell RIM!: Against ...
Health Care: Drugs
Cytokinetics Inc. (CYTK: NASDAQ)
$0.88 -0.02 | -2.17%
06/04/12 - 03:59 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -47.86M | -49.29M | 24.54M | -56.37M |
| Operating Gains/Losses | 3.00K | -13.00K | -40.00K | 3.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 32.00K | 134.00K | 41.00K | -145.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 162.00K | -536.00K | 334.00K | -6.00K |
| (Decrease) Increase In Other Current Liabilities | -2.27M | -1.38M | -1.18M | -1.56M |
| (Increase) Decrease In Other Working Capital | 12.00K | 0.00 | -23.74M | -12.11M |
| Other Non-Cash Items | 3.26M | 4.05M | 6.61M | 6.22M |
| Net Cash From Continuing Operations | -45.60M | -44.83M | 8.42M | -61.33M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -45.60M | -44.83M | 8.42M | -61.33M |
| Sale of Property, Plant & Equipment | 3.00K | 14.00K | 74.00K | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 12.61M |
| Purchases of Property, Plant & Equipment | -443.00K | -493.00K | -550.00K | -658.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -24.46M |
| Other Cash from Investing Activities | -47.43M | 886.00K | 1.11M | 2.55M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 25.30M | 34.24M | -53.48M | -9.97M |
| Issuance of Debt | 0.00 | 0.00 | 19.29M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 20.02M | 425.00K | 13.77M | 599.00K |
| Repayment of Long-Term Debt | -833.00K | -11.82M | -4.28M | -4.05M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 2.42M | 13.94M | 20.00K | 0.00 |
| Net Cash From Financing Activities | 21.61M | 2.55M | 28.81M | -3.45M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 1.32M | -8.05M | -16.26M | -74.74M |
Portfolios with CYTK
- Portfolio NameUser Type
- Contributor$5 Stocks That Analysts Exp...
- UserBlue OAK
- UserDaveofDuke1111
- UserASCO 2010 Part 2
- ContributorBarron's Insider Purchases ...
- UserASCO 2009 Nymph's Watch List.
- UserHot Biotech Stocks II
- UserLet's Go Channeling
- UserDizziMage's Port
- Usermileslb Fidelity IRA
Latest CYTK Headlines from TheStreet
- Cytokinetics CEO Discusses Q3 2010 Results - Earnings Call Transcript 10.28.10 | 11:10 pm
- $5 Stocks That Analysts Expect to Double 08.02.10 | 06:08 am
- Cytokinetics Inc. Q2 2010 Earnings Call Transcript 07.29.10 | 03:07 am
- Cytokinetics Ends Cancer Deal With GlaxoSmithKline 12.09.09 | 04:12 pm
- Movers Roundup: Manitowoc, Symantec 10.29.09 | 02:10 pm
- Cytokinetics Shares Fall On Drug Development Delay 10.29.09 | 12:10 pm
- Harmonic, SkyPeople: Midday Volume Plays 10.29.09 | 12:10 pm
- High Times
09.29.09 | 10:09 am - Cytokinetics: Pump Up The Volume 09.25.09 | 03:09 pm
- Optimer Soars on Antibiotic Data 11.11.08 | 12:11 pm
Press Releases for CYTK
Partner Headlines for CYTK
- Rodman & Renshaw Reiterates Cytokinetics Market Outperform, $4 PT - Benzinga 11.01.11 | 04:11 pm
- 16 Small Caps With Cash to Cover 1+ Years of Operating Expenses - Seeking Alpha 04.20.11 | 04:04 am
- Cytokinetics Up 9% (CYTK) - Benzinga 04.12.11 | 09:04 am
- Cytokinetics: Most Recent Victim of Unjustified Biotech Sell-Off - Seeking Alpha 12.19.10 | 07:12 am
- UPDATE 1-Cytokinetics' Lou Gehrig's drug gets orphan status - Reuters 03.10.10 | 09:03 am
